Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome. (Q54061823)

24 May 2018

title

Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome. (English)

1 reference

24 May 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

1 reference

1 reference

Hacihanefioglu B

1

1 reference

24 May 2018

Seyisoglu H

2

1 reference

24 May 2018

Karsidag K

3

1 reference

24 May 2018

Elter K

4

1 reference

24 May 2018

Aksu F

5

1 reference

24 May 2018

Yilmaz T

6

1 reference

24 May 2018

Gurol AO

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 February 2000

1 reference

24 May 2018

published in

Fertility and Sterility

1 reference

24 May 2018

volume

73

1 reference

24 May 2018

issue

2

1 reference

24 May 2018

page(s)

261-265

1 reference

24 May 2018

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Insulin Resistance in Secondary Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

The role of the renin-angiotensin system in insulin sensitivity in normotensive subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Serum total renin is elevated in women with polycystic ovarian syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Clinical assessment of body hair growth in women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

The significance of polycystic-appearing ovaries versus normal-appearing ovaries in patients with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Total renin after gonadotropin stimulation in polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

Effects of angiotensin II on insulin sensitivity: a placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2899%2900497-5

10.1016/S0015-0282(99)00497-5

7 January 2021

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018